133 related articles for article (PubMed ID: 24274878)
1. Host genetic variants in obesity-related nonalcoholic fatty liver disease.
Mehta R; Birerdinc A; Younossi ZM
Clin Liver Dis; 2014 Feb; 18(1):249-67. PubMed ID: 24274878
[TBL] [Abstract][Full Text] [Related]
2. Update on nonalcoholic fatty liver disease: genes involved in nonalcoholic fatty liver disease and associated inflammation.
Tilg H; Moschen A
Curr Opin Clin Nutr Metab Care; 2010 Jul; 13(4):391-6. PubMed ID: 20473151
[TBL] [Abstract][Full Text] [Related]
3. A gene variant of PNPLA3, but not of APOC3, is associated with histological parameters of NAFLD in an obese population.
Verrijken A; Beckers S; Francque S; Hilden H; Caron S; Zegers D; Ruppert M; Hubens G; Van Marck E; Michielsen P; Staels B; Taskinen MR; Van Hul W; Van Gaal L
Obesity (Silver Spring); 2013 Oct; 21(10):2138-45. PubMed ID: 23512881
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms in nonalcoholic fatty liver disease: a study in Brazilian patients.
Domenici FA; Brochado MJ; Martinelli Ade L; Zucoloto S; da Cunha SF; Vannucchi H
Gene; 2013 Oct; 529(2):326-31. PubMed ID: 23891824
[TBL] [Abstract][Full Text] [Related]
5. The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liver.
Valenti L; Nobili V; Al-Serri A; Rametta R; Leathart JB; Zappa MA; Dongiovanni P; Fracanzani AL; Alterio A; Roviaro G; Daly AK; Fargion S; Day CP
J Hepatol; 2011 Dec; 55(6):1409-14. PubMed ID: 21777557
[TBL] [Abstract][Full Text] [Related]
6. Altered lipid metabolism in Hfe-knockout mice promotes severe NAFLD and early fibrosis.
Tan TC; Crawford DH; Jaskowski LA; Murphy TM; Heritage ML; Subramaniam VN; Clouston AD; Anderson GJ; Fletcher LM
Am J Physiol Gastrointest Liver Physiol; 2011 Nov; 301(5):G865-76. PubMed ID: 21817060
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms of microsomal triglyceride transfer protein gene and phosphatidylethanolamine N-methyltransferase gene in alcoholic and nonalcoholic fatty liver disease in Koreans.
Jun DW; Han JH; Jang EC; Kim SH; Kim SH; Jo YJ; Park YS; Chae JD
Eur J Gastroenterol Hepatol; 2009 Jun; 21(6):667-72. PubMed ID: 19262398
[TBL] [Abstract][Full Text] [Related]
8. The genetic backgrounds in nonalcoholic fatty liver disease.
Seko Y; Yamaguchi K; Itoh Y
Clin J Gastroenterol; 2018 Apr; 11(2):97-102. PubMed ID: 29492830
[TBL] [Abstract][Full Text] [Related]
9. I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease.
Valenti L; Alisi A; Galmozzi E; Bartuli A; Del Menico B; Alterio A; Dongiovanni P; Fargion S; Nobili V
Hepatology; 2010 Oct; 52(4):1274-80. PubMed ID: 20648474
[TBL] [Abstract][Full Text] [Related]
10. Roles of PPARs in NAFLD: potential therapeutic targets.
Tailleux A; Wouters K; Staels B
Biochim Biophys Acta; 2012 May; 1821(5):809-18. PubMed ID: 22056763
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease.
Richart C; Auguet T; Terra X
N Engl J Med; 2010 Jul; 363(2):193-4; author reply 195. PubMed ID: 20647217
[No Abstract] [Full Text] [Related]
12. APOC3 polymorphisms and non-alcoholic fatty liver disease: resolving some doubts and raising others.
Romero-Gómez M
J Hepatol; 2011 Dec; 55(6):1184-6. PubMed ID: 21704003
[No Abstract] [Full Text] [Related]
13. Circulating triacylglycerol signatures in nonalcoholic fatty liver disease associated with the I148M variant in PNPLA3 and with obesity.
Hyysalo J; Gopalacharyulu P; Bian H; Hyötyläinen T; Leivonen M; Jaser N; Juuti A; Honka MJ; Nuutila P; Olkkonen VM; Oresic M; Yki-Järvinen H
Diabetes; 2014 Jan; 63(1):312-22. PubMed ID: 24009255
[TBL] [Abstract][Full Text] [Related]
14. The potential role of genes in nonalcoholic fatty liver disease.
Day CP
Clin Liver Dis; 2004 Aug; 8(3):673-91, xi. PubMed ID: 15331069
[TBL] [Abstract][Full Text] [Related]
15. Insights from Genome-Wide Association Analyses of Nonalcoholic Fatty Liver Disease.
Kahali B; Halligan B; Speliotes EK
Semin Liver Dis; 2015 Nov; 35(4):375-91. PubMed ID: 26676813
[TBL] [Abstract][Full Text] [Related]
16. [Influence of non-alcoholic fatty liver disease on cardiovascular disease].
Ampuero J; Romero-Gómez M
Gastroenterol Hepatol; 2012 Oct; 35(8):585-93. PubMed ID: 22541252
[TBL] [Abstract][Full Text] [Related]
17. Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease.
Daly AK; Ballestri S; Carulli L; Loria P; Day CP
Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):253-63. PubMed ID: 21476920
[TBL] [Abstract][Full Text] [Related]
18. Genetic variation in PNPLA3 but not APOC3 influences liver fat in non-alcoholic fatty liver disease.
Hyysalo J; Stojkovic I; Kotronen A; Hakkarainen A; Sevastianova K; Makkonen J; Lundbom N; Rissanen A; Krauss RM; Melander O; Orho-Melander M; Yki-Järvinen H
J Gastroenterol Hepatol; 2012 May; 27(5):951-6. PubMed ID: 22141340
[TBL] [Abstract][Full Text] [Related]
19. The role of apolipoprotein A5 in non-alcoholic fatty liver disease.
Ress C; Moschen AR; Sausgruber N; Tschoner A; Graziadei I; Weiss H; Schgoer W; Ebenbichler CF; Konrad RJ; Patsch JR; Tilg H; Kaser S
Gut; 2011 Jul; 60(7):985-91. PubMed ID: 21339203
[TBL] [Abstract][Full Text] [Related]
20. Gene polymorphisms associated with non-alcoholic fatty liver disease and coronary artery disease: a concise review.
Li XL; Sui JQ; Lu LL; Zhang NN; Xu X; Dong QY; Xin YN; Xuan SY
Lipids Health Dis; 2016 Mar; 15():53. PubMed ID: 26965314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
